Jupiter Endovascular
Chuck Love serves as the Chief Science Officer at Jupiter Endovascular and has held the position of Vice President of Cardiovascular Technologies at Neptune Medical. In addition to these roles, Chuck Love acts as an Advisor for LimFlow SA and is a Senior Executive in Residence at Bounce Innovation. Previously, Chuck Love was the Senior Vice President of Global Clinical Operations & Regulatory Affairs at ROX Medical.
This person is not in any teams
This person is not in any offices
Jupiter Endovascular
Imagine a world where you could bring the precision and control of surgery to catheter-based therapies. For decades, endovascular procedures have been constrained by the technological limitations of catheters that lose stability and control within the anatomy. We have created a new class of therapies to overcome these constraints by using Endoportal Control to mimic the precision and control of direct surgical access, while maintaining the minimally invasive profile of an endovascular intervention. Our vision is big, spanning the breadth of cardiovascular disease where we see compelling opportunities to reimagine therapies for millions of patients. Jupiter Endovascular is a medical technology startup located in the San Francisco Bay Area, led by a team of successful medical device entrepreneurs. We have big ambitions, with a culture built on innovation, teamwork, and speed. We have raised capital from a diversified investor base, including venture capital, private equity, corporate strategic investors, and clinician angel investors.